New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) and published in Nature ...

The findings raise concerns that patients may be skipping or delaying proven treatments in favor of the off-label regimen.

Three weeks after taking over as CEO of Lexicon Pharmaceuticals back in 2024, Michael Exton suggested the company close its ...

Learn who qualifies for Medicare’s GLP-1 Bridge, when $50 Wegovy and Zepbound access begins, and key rules beneficiaries need ...

About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year. It was the third straight ...

May 13 (Reuters) - U.S.-based drugmaker Eli Lilly on Wednesday launched its Alzheimer's drug Lormalzi, also known as ...

Kyle Diamantas is a lawyer, not a doctor, who will oversee products making up a quarter of the U.S. economy ...

Baxfendy can control hypertension even in patients for whom other drugs have failed ...

FDA Commissioner Marty Makary, MD, MPH, resigned Tuesday, according to The Associated Press, just 13 months after being ...

Despite upbeat Ohio stops, Robert F. Kennedy Jr. couldn’t dodge questions about the Trump administration’s more controversial ...

LOS ANGELES (AP) — The wide-ranging prosecution in the death of “Friends” star Matthew Perry is coming to a close. Five ...

Crisis Conversations continues as we look at how the war on Iran could start affecting healthcare — from rising medicine ...